Atlas Trials

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

Clinical trial NCT00096161 · COMPLETED

Trial details

NCT number
NCT00096161
Sponsor
Fred Hutchinson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositiveGraft Versus Host DiseaseHodgkin LymphomaMyelodysplastic/Myeloproliferative NeoplasmNon-Hodgkin LymphomaPlasma Cell MyelomaWaldenstrom Macroglobulinemia
Start date
2003-05-01
Primary completion
2015-02-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.